✦ LIBER ✦

Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy

✍ Scribed by D. Chadwick; D. Smith; P. Crawford; B. Harrison

Book ID: 117832340
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 69 KB
Volume: 9
Category: Article
ISSN: 1059-1311
DOI: 10.1053/seiz.2000.0448

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled, double-blind cross

A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsy

✍ A. Richens; G. Mawer; P. Crawford; B. Harrison 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 61 KB

A double-blind, placebo-controlled study

A double-blind, placebo-controlled study of remacemide hydrochloride in patients with refractory epilepsy following pre-surgical assessment

✍ O Devinsky; B Vazquez; E Faught; I.E Leppik; J.M Pellock; S Schachter; V Alderfe 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 56 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

✍ Jonathan J. Halford; Elinor Ben-Menachem; Patrick Kwan; Seth Ness; Jennifer Schm 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 459 KB

55 HEMODYNAMIC EFFECTS AND SAFETY OF ONE

55 HEMODYNAMIC EFFECTS AND SAFETY OF ONE-MONTH SIMVASTATIN TREATMENT IN PATIENTS WITH CIRRHOSIS AND PORTAL HYPERTENSION. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER TRIAL

✍ J.G. Abraldes; A. Albillos; J. Turnes; R. Banares; R. Gonzalez; M. Gonzalez; J.C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

A double-blind, placebo-controlled evalu

A double-blind, placebo-controlled evaluation of the efficacy and safety of loreclezole as add-on therapy in patients with uncontrolled partial seizures

✍ T Rentmeester; A Janssen; J Hulsman; F Scholtes; B van der Kleij; J Overweg; J M 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 655 KB

Sixty-two patients with uncontrolled partial seizures participated in a 12-week, double-blind, placebo-controlled add-on-trial. Thirty-two patients received loreclezole and 30 a placebo as add-on therapy. Loreclezole was targeted at a plasma level of 1-2 mg/l. In spite of an antiepileptic therapy, u

Safety and efficacy of linagliptin as ad

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

✍ M.-R. Taskinen; J. Rosenstock; I. Tamminen; R. Kubiak; S. Patel; K. A. Dugi; H.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB